Ganga Pharmaceuticals Limited

GANGAPHARM

Small Cap | Pharmaceuticals
₹12
+0 (+0%)

Stock price as on 12 Feb 2026 at 00:00 AM

Ganga pharmaceuticals limited share price update

As of the latest trading session, Ganga Pharmaceuticals Limited share price is currently at ₹12, which is up by ₹0 from its previous closing. Today th...

Ganga Pharmaceuticals Limited stock performance

Today’s low

₹12

Today’s high

₹12

₹12

52 week low

₹9.35

52 week high

₹14.8

₹12
Open
₹12.00
Previous close
₹12.00
Share volume
8,000
Total traded value (Lakh)
₹0.96
Upper circuit
₹14.40
Lower circuit
₹9.60

Ganga Pharmaceuticals Limited fundamentals

Market cap (Cr)
₹0.00
P/E ratio (TTM)
0
Book value per share
₹0.00
Beta
0
Return on equity
0%
Earnings per share (TTM)
₹0.00
Dividend yield
0%
Net profit/quarter (Cr)
₹0.00

Ganga Pharmaceuticals Limited technical summary

₹12
0 ▼
0
Bearish
0
Bullish
5 Day0
10 Day0
12 Day0
20 Day0
26 Day0
50 Day0
100 Day0
200 Day0
5 Day12.3
10 Day13.2
12 Day13
20 Day12.5
26 Day13.5
50 Day18.5
100 Day15.6
200 Day11.9

12

PIVOT

First support
₹12.00
First resistance
₹12.00
Second support
₹12.00
Second resistance
₹12.00
Third support
₹12.00
Third resistance
₹12.00
RSI
58.88
ADX
40.26
MACD
0
Williams % R
-50.45
Commodity Channel Index (CCI)
-18.58
Date
12 Feb 2026
Same day
8,000
Week
8,000
Month
12,000
1 year
-1.43
3 years
2.71
Over 1 month
1.69%
Over 1 year
-12.08%
Over 3 months
2.73%
Over 3 years
-2.63%
Over 6 months
-17.8%
Over 6 years
14.86%

Investment Returns

Over 1 Month1.69%
Over 3 Months2.73%
Over 6 Months17.8%
Over 1 Year12.08%

Ganga Pharmaceuticals Limited Shareholding pattern


Public
49.08%
Promoter holdings
50.91%
FII
0%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Sharma Bharat B

14,56,585 (24.64%)

Shareholding of Promoter and Promoter Group

Srijna Sharma

4,41,905 (7.48%)

Shareholding of Promoter and Promoter Group

Bhavesh Dhirajlal Tanna

3,91,000 (6.61%)

Public Shareholding

Plutus Capital Management Llp

3,75,000 (6.34%)

Public Shareholding

Lenus Finvest Private Limited

3,75,000 (6.34%)

Public Shareholding

Promoter sharesShareCategory
Sharma Bharat B14,56,585 (24.64%)Shareholding of Promoter and Promoter Group
Srijna Sharma4,41,905 (7.48%)Shareholding of Promoter and Promoter Group
Bhavesh Dhirajlal Tanna3,91,000 (6.61%)Public Shareholding
Plutus Capital Management Llp3,75,000 (6.34%)Public Shareholding
Lenus Finvest Private Limited3,75,000 (6.34%)Public Shareholding
Anagh Bharat Sharma3,60,000 (6.09%)Shareholding of Promoter and Promoter Group
Brijmohan Sharma Huf3,49,500 (5.91%)Shareholding of Promoter and Promoter Group
Prakash Dhirajlal Tanna3,25,000 (5.5%)Public Shareholding
Bharat Brijmohan Sharma Huf Sharma1,90,000 (3.21%)Shareholding of Promoter and Promoter Group
Niranjan Kumar Goel1,44,000 (2.44%)Public Shareholding
Usha Shukla95,110 (1.61%)Shareholding of Promoter and Promoter Group
Amit Shukla76,450 (1.29%)Shareholding of Promoter and Promoter Group
Akshay Amarnath Sharma72,000 (1.22%)Public Shareholding
Sanjay Dhansukhlal Shah72,000 (1.22%)Public Shareholding
Ankita Amit Shukla40,000 (0.68%)Shareholding of Promoter and Promoter Group

About Ganga Pharmaceuticals Limited

Ganga Pharmaceuticals Limited was incorporated as a Public Limited Company in Aug.'94 and promoted by Brij Mohan Sharma. The Company is engaged in the business of manufacturing & trading in Pharmaceuticals & allied products (Ayurveda). In Apr.'95, the company took over Ganga pharmaceuticals, a proprietary concern (owned by the same promoter), which was manufacturing and marketing ayurvedic products since the last two decades. The company which manufactures ayurvedic medicines, started commercial production in Apr.'95. In Jul.'96, it ca

Parent Organisation

Indian Private

NSE Symbol

Ganga Pharmaceuticals Limited

Founded

1989

Ganga Pharmaceuticals Limited CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

BALCO

SOLVE PLASTIC PRODUCTS L

31.4
+8.55 (+37.42%)
ADISOFT

ADISOFT TECHNOLOGIES LTD

215.25
+43.25 (+25.15%)
CEMPRO

CEMINDIA PROJECTS LIMITED

815.25
+135.85 (+20%)
CEMPRO

CEMINDIA PROJECTS LIMITED

814.55
+135.75 (+20%)
View all

Top gainers

BAJAJ-AUTO

BAJAJ AUTO LIMITED

9994
+450.50 (+4.72%)
SUNPHARMA

SUN PHARMACEUTICAL IND L

1808.3
+29.60 (+1.66%)
INFY

INFOSYS LIMITED

1181.8
+14.30 (+1.22%)
TECHM

TECH MAHINDRA LIMITED

1473.5
+13.70 (+0.94%)
View all

Top losers

TMPV

TATA MOTORS PASS VEH LTD

341.55
-11.15 (-3.16%)
ETERNAL

ETERNAL LIMITED

247.03
-7.00 (-2.76%)
HINDALCO

HINDALCO INDUSTRIES LTD

1038
-29.20 (-2.74%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2250.9
-63.50 (-2.74%)
View all

Frequently asked questions



Related tags


You are here


Related links


Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

Powered by Bajaj Financial Securities Limited (Bajaj Broking)